4//SEC Filing
GRYSKA DAVID W 4
Accession 0000899243-23-016426
CIK 0001813814other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:04 PM ET
Size
10.9 KB
Accession
0000899243-23-016426
Insider Transaction Report
Form 4
GRYSKA DAVID W
Director
Transactions
- Award
Director's Deferred Share Units
2023-06-21+13,131→ 13,131 total→ Common Shares - Award
Common Shares
2023-06-21+13,851→ 13,851 total - Award
Stock Option (Right to Buy)
2023-06-21+37,594→ 37,594 totalExercise: $3.61Exp: 2033-06-20→ Common Shares (37,594 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Common Share of the Issuer. These RSUs will vest in three equal annual installments over such three-year period; provided, that in the event that the Reporting Person's continuous service as a member of the Board terminates for any reason other than for cause after the first anniversary of the grant date, a portion of these RSUs that would have vested on the next annual vesting date following the date of departure will immediately vest in full as of the date of termination of service on a prorated basis.
- [F2]The shares underlying the option shall vest and become exercisable 1/3 on June 21, 2024, with the remaining portion vesting in equal monthly installments over the two years thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date.
- [F3]Represents Directors' Deferred Share Units ("DDSUs") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the "Plan"). DDSUs will vest 1/3 on June 21, 2024, with the remaining portion vesting in equal monthly installments over the two years thereafter. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Common Share). Pursuant to the Plan, the fair market value of a Common Share is equal to the volume weighted average trading price of a Common Share on the Nasdaq Stock Market for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators (defined in the Plan).
Documents
Issuer
Mind Medicine (MindMed) Inc.
CIK 0001813814
Entity typeother
Related Parties
1- filerCIK 0001202335
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 6:04 PM ET
- Size
- 10.9 KB